Capricor Therapeutics Files For Mixed Shelf Offering Of Up To $150M
Portfolio Pulse from Benzinga Newsdesk
Capricor Therapeutics has filed for a mixed shelf offering of up to $150 million, according to an SEC filing.
June 14, 2024 | 8:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Capricor Therapeutics has filed for a mixed shelf offering of up to $150 million, which could lead to stock dilution and impact the stock price in the short term.
A mixed shelf offering allows the company to issue various types of securities, which can lead to stock dilution. This often results in a short-term negative impact on the stock price as the market adjusts to the potential increase in supply.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100